Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function

Charles Keller, Benjamin R. Arenkiel, Cheryl M. Coffin, Nabeel El-Bardeesy, Ronald A. DePinho, Mario R. Capecchi

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

Alveolar rhabdomyosarcoma is an aggressive childhood muscle cancer for which outcomes are poor when the disease is advanced. Although well-developed mouse models exist for embryonal and pleomorphic rhabdomyosarcomas, neither a spontaneous nor a transgenic mouse model of alveolar rhabdomyosarcoma has yet been reported. We report the first mouse model of alveolar rhabdomyosarcoma using a conditional Pax3:Fkhr knock-in allele whose activation in late embryogenesis and postnatally is targeted to terminally differentiating Myf6-expressing skeletal muscle. In these mice, alveolar rhabdomyosarcomas occur but at low frequency, and Fkhr haploinsufficiency does not appear to accelerate tumorigenesis. However, Pax3:Fkhr homozygosity with accompanying Ink4a/ARF or Trp53 pathway disruption, by means of conditional Trp53 or Ink4a/ARF loss of function, substantially increases the frequencies of tumor formation. These results of successful tumor generation postnatally from a target pool of differentiating myofibers are in sharp contrast to the birth defects and lack of tumors for mice with prenatal and postnatal satellite cell triggering of Pax3:Fkhr. Furthermore, these murine alveolar rhabdomyosarcomas have an immunohistochemical profile similar to human alveolar rhabdomyosarcoma, suggesting that this conditional mouse model will be relevant to study of the disease and will be useful for preclinical therapeutic testing.

Original languageEnglish (US)
Pages (from-to)2614-2626
Number of pages13
JournalGenes and Development
Volume18
Issue number21
DOIs
StatePublished - Nov 1 2004
Externally publishedYes

Fingerprint

Alveolar Rhabdomyosarcoma
Muscle Neoplasms
Embryonal Rhabdomyosarcoma
Haploinsufficiency
Neoplasms
Transgenic Mice
Embryonic Development
Carcinogenesis
Skeletal Muscle
Alleles

Keywords

  • Alveolar rhabdomyosarcoma
  • Chromosome translocation
  • Fkhr
  • FoxO1A
  • Pax3
  • Pax3:Fkhr
  • Satellite cell

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., & Capecchi, M. R. (2004). Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. Genes and Development, 18(21), 2614-2626. https://doi.org/10.1101/gad.1244004

Alveolar rhabdomyosarcomas in conditional Pax3 : Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. / Keller, Charles; Arenkiel, Benjamin R.; Coffin, Cheryl M.; El-Bardeesy, Nabeel; DePinho, Ronald A.; Capecchi, Mario R.

In: Genes and Development, Vol. 18, No. 21, 01.11.2004, p. 2614-2626.

Research output: Contribution to journalArticle

Keller, C, Arenkiel, BR, Coffin, CM, El-Bardeesy, N, DePinho, RA & Capecchi, MR 2004, 'Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function', Genes and Development, vol. 18, no. 21, pp. 2614-2626. https://doi.org/10.1101/gad.1244004
Keller, Charles ; Arenkiel, Benjamin R. ; Coffin, Cheryl M. ; El-Bardeesy, Nabeel ; DePinho, Ronald A. ; Capecchi, Mario R. / Alveolar rhabdomyosarcomas in conditional Pax3 : Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. In: Genes and Development. 2004 ; Vol. 18, No. 21. pp. 2614-2626.
@article{31ee4ae3c30a4e7b98a1049ed33b15c3,
title = "Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function",
abstract = "Alveolar rhabdomyosarcoma is an aggressive childhood muscle cancer for which outcomes are poor when the disease is advanced. Although well-developed mouse models exist for embryonal and pleomorphic rhabdomyosarcomas, neither a spontaneous nor a transgenic mouse model of alveolar rhabdomyosarcoma has yet been reported. We report the first mouse model of alveolar rhabdomyosarcoma using a conditional Pax3:Fkhr knock-in allele whose activation in late embryogenesis and postnatally is targeted to terminally differentiating Myf6-expressing skeletal muscle. In these mice, alveolar rhabdomyosarcomas occur but at low frequency, and Fkhr haploinsufficiency does not appear to accelerate tumorigenesis. However, Pax3:Fkhr homozygosity with accompanying Ink4a/ARF or Trp53 pathway disruption, by means of conditional Trp53 or Ink4a/ARF loss of function, substantially increases the frequencies of tumor formation. These results of successful tumor generation postnatally from a target pool of differentiating myofibers are in sharp contrast to the birth defects and lack of tumors for mice with prenatal and postnatal satellite cell triggering of Pax3:Fkhr. Furthermore, these murine alveolar rhabdomyosarcomas have an immunohistochemical profile similar to human alveolar rhabdomyosarcoma, suggesting that this conditional mouse model will be relevant to study of the disease and will be useful for preclinical therapeutic testing.",
keywords = "Alveolar rhabdomyosarcoma, Chromosome translocation, Fkhr, FoxO1A, Pax3, Pax3:Fkhr, Satellite cell",
author = "Charles Keller and Arenkiel, {Benjamin R.} and Coffin, {Cheryl M.} and Nabeel El-Bardeesy and DePinho, {Ronald A.} and Capecchi, {Mario R.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1101/gad.1244004",
language = "English (US)",
volume = "18",
pages = "2614--2626",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "21",

}

TY - JOUR

T1 - Alveolar rhabdomyosarcomas in conditional Pax3

T2 - Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function

AU - Keller, Charles

AU - Arenkiel, Benjamin R.

AU - Coffin, Cheryl M.

AU - El-Bardeesy, Nabeel

AU - DePinho, Ronald A.

AU - Capecchi, Mario R.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Alveolar rhabdomyosarcoma is an aggressive childhood muscle cancer for which outcomes are poor when the disease is advanced. Although well-developed mouse models exist for embryonal and pleomorphic rhabdomyosarcomas, neither a spontaneous nor a transgenic mouse model of alveolar rhabdomyosarcoma has yet been reported. We report the first mouse model of alveolar rhabdomyosarcoma using a conditional Pax3:Fkhr knock-in allele whose activation in late embryogenesis and postnatally is targeted to terminally differentiating Myf6-expressing skeletal muscle. In these mice, alveolar rhabdomyosarcomas occur but at low frequency, and Fkhr haploinsufficiency does not appear to accelerate tumorigenesis. However, Pax3:Fkhr homozygosity with accompanying Ink4a/ARF or Trp53 pathway disruption, by means of conditional Trp53 or Ink4a/ARF loss of function, substantially increases the frequencies of tumor formation. These results of successful tumor generation postnatally from a target pool of differentiating myofibers are in sharp contrast to the birth defects and lack of tumors for mice with prenatal and postnatal satellite cell triggering of Pax3:Fkhr. Furthermore, these murine alveolar rhabdomyosarcomas have an immunohistochemical profile similar to human alveolar rhabdomyosarcoma, suggesting that this conditional mouse model will be relevant to study of the disease and will be useful for preclinical therapeutic testing.

AB - Alveolar rhabdomyosarcoma is an aggressive childhood muscle cancer for which outcomes are poor when the disease is advanced. Although well-developed mouse models exist for embryonal and pleomorphic rhabdomyosarcomas, neither a spontaneous nor a transgenic mouse model of alveolar rhabdomyosarcoma has yet been reported. We report the first mouse model of alveolar rhabdomyosarcoma using a conditional Pax3:Fkhr knock-in allele whose activation in late embryogenesis and postnatally is targeted to terminally differentiating Myf6-expressing skeletal muscle. In these mice, alveolar rhabdomyosarcomas occur but at low frequency, and Fkhr haploinsufficiency does not appear to accelerate tumorigenesis. However, Pax3:Fkhr homozygosity with accompanying Ink4a/ARF or Trp53 pathway disruption, by means of conditional Trp53 or Ink4a/ARF loss of function, substantially increases the frequencies of tumor formation. These results of successful tumor generation postnatally from a target pool of differentiating myofibers are in sharp contrast to the birth defects and lack of tumors for mice with prenatal and postnatal satellite cell triggering of Pax3:Fkhr. Furthermore, these murine alveolar rhabdomyosarcomas have an immunohistochemical profile similar to human alveolar rhabdomyosarcoma, suggesting that this conditional mouse model will be relevant to study of the disease and will be useful for preclinical therapeutic testing.

KW - Alveolar rhabdomyosarcoma

KW - Chromosome translocation

KW - Fkhr

KW - FoxO1A

KW - Pax3

KW - Pax3:Fkhr

KW - Satellite cell

UR - http://www.scopus.com/inward/record.url?scp=7544243041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7544243041&partnerID=8YFLogxK

U2 - 10.1101/gad.1244004

DO - 10.1101/gad.1244004

M3 - Article

C2 - 15489287

AN - SCOPUS:7544243041

VL - 18

SP - 2614

EP - 2626

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 21

ER -